160 related articles for article (PubMed ID: 12755840)
1. Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease.
Baumgart DC; Wiedenmann B; Dignass AU
Aliment Pharmacol Ther; 2003 May; 17(10):1273-81. PubMed ID: 12755840
[TBL] [Abstract][Full Text] [Related]
2. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
Baumgart DC; Pintoffl JP; Sturm A; Wiedenmann B; Dignass AU
Am J Gastroenterol; 2006 May; 101(5):1048-56. PubMed ID: 16573777
[TBL] [Abstract][Full Text] [Related]
3. Medium-term results of oral tacrolimus treatment in refractory inflammatory bowel disease.
Ng SC; Arebi N; Kamm MA
Inflamm Bowel Dis; 2007 Feb; 13(2):129-34. PubMed ID: 17206694
[TBL] [Abstract][Full Text] [Related]
4. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
Fellermann K; Ludwig D; Stahl M; David-Walek T; Stange EF
Am J Gastroenterol; 1998 Oct; 93(10):1860-6. PubMed ID: 9772045
[TBL] [Abstract][Full Text] [Related]
5. Effect of oral tacrolimus (FK 506) on steroid-refractory moderate/severe ulcerative colitis.
Högenauer C; Wenzl HH; Hinterleitner TA; Petritsch W
Aliment Pharmacol Ther; 2003 Aug; 18(4):415-23. PubMed ID: 12940927
[TBL] [Abstract][Full Text] [Related]
6. Effects of oral tacrolimus as a rapid induction therapy in ulcerative colitis.
Kawakami K; Inoue T; Murano M; Narabayashi K; Nouda S; Ishida K; Abe Y; Nogami K; Hida N; Yamagami H; Watanabe K; Umegaki E; Nakamura S; Arakawa T; Higuchi K
World J Gastroenterol; 2015 Feb; 21(6):1880-6. PubMed ID: 25684955
[TBL] [Abstract][Full Text] [Related]
7. Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis.
Hoffmann P; Wehling C; Krisam J; Pfeiffenberger J; Belling N; Gauss A
World J Gastroenterol; 2019 Apr; 25(13):1603-1617. PubMed ID: 30983820
[TBL] [Abstract][Full Text] [Related]
8. Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis.
Yamamoto S; Nakase H; Mikami S; Inoue S; Yoshino T; Takeda Y; Kasahara K; Ueno S; Uza N; Kitamura H; Tamaki H; Matsuura M; Inui K; Chiba T
Aliment Pharmacol Ther; 2008 Sep; 28(5):589-97. PubMed ID: 18549460
[TBL] [Abstract][Full Text] [Related]
9. [Safety and efficacy of oral tacrolimus in the treatment of paediatric inflammatory bowel disease].
Navas López VM; Blasco Alonso J; Sierra Salinas C; Barco Gálvez A; Vicioso Recio MI
An Pediatr (Barc); 2009 Jun; 70(6):519-25. PubMed ID: 19427822
[TBL] [Abstract][Full Text] [Related]
10. Medium to long-term efficacy and safety of oral tacrolimus in moderate to severe steroid refractory ulcerative colitis.
Olmedo Martín RV; Amo Trillo V; González Grande R; Jiménez Pérez M
Rev Esp Enferm Dig; 2017 Aug; 109(8):559-565. PubMed ID: 28617029
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patients.
Protic M; Seibold F; Schoepfer A; Radojicic Z; Juillerat P; Bojic D; Mwinyi J; Mottet C; Jojic N; Beglinger C; Vavricka S; Rogler G; Frei P
J Crohns Colitis; 2014 Nov; 8(11):1427-37. PubMed ID: 24908178
[TBL] [Abstract][Full Text] [Related]
12. A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis.
Ogata H; Matsui T; Nakamura M; Iida M; Takazoe M; Suzuki Y; Hibi T
Gut; 2006 Sep; 55(9):1255-62. PubMed ID: 16484504
[TBL] [Abstract][Full Text] [Related]
13. Oral tacrolimus as maintenance therapy for refractory ulcerative colitis--an analysis of outcomes in two London tertiary centres.
Landy J; Wahed M; Peake ST; Hussein M; Ng SC; Lindsay JO; Hart AL
J Crohns Colitis; 2013 Dec; 7(11):e516-21. PubMed ID: 23623737
[TBL] [Abstract][Full Text] [Related]
14. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
15. Mucosal healing with oral tacrolimus is associated with favorable medium- and long-term prognosis in steroid-refractory/dependent ulcerative colitis patients.
Miyoshi J; Matsuoka K; Inoue N; Hisamatsu T; Ichikawa R; Yajima T; Okamoto S; Naganuma M; Sato T; Kanai T; Ogata H; Iwao Y; Hibi T
J Crohns Colitis; 2013 Dec; 7(12):e609-14. PubMed ID: 23680174
[TBL] [Abstract][Full Text] [Related]
16. Response of refractory colitis to intravenous or oral tacrolimus (FK506).
Fellermann K; Tanko Z; Herrlinger KR; Witthoeft T; Homann N; Bruening A; Ludwig D; Stange EF
Inflamm Bowel Dis; 2002 Sep; 8(5):317-24. PubMed ID: 12479646
[TBL] [Abstract][Full Text] [Related]
17. Oral tacrolimus for pediatric steroid-resistant ulcerative colitis.
Navas-López VM; Blasco Alonso J; Serrano Nieto MJ; Girón Fernández-Crehuet F; Argos Rodriguez MD; Sierra Salinas C
J Crohns Colitis; 2014 Jan; 8(1):64-9. PubMed ID: 23582736
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Combination Antibiotic Therapy for Refractory Pediatric Inflammatory Bowel Disease.
Breton J; Kastl A; Hoffmann N; Rogers R; Grossman AB; Mamula P; Kelsen JR; Baldassano RN; Albenberg L
Inflamm Bowel Dis; 2019 Aug; 25(9):1586-1593. PubMed ID: 30715364
[TBL] [Abstract][Full Text] [Related]
19. The effect of tacrolimus (FK-506) on Japanese patients with refractory Crohn's disease.
Tamaki H; Nakase H; Matsuura M; Inoue S; Mikami S; Ueno S; Uza N; Kitamura H; Kasahara K; Chiba T
J Gastroenterol; 2008; 43(10):774-9. PubMed ID: 18958546
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus salvage in anti-tumor necrosis factor antibody treatment-refractory Crohn's disease.
Gerich ME; Pardi DS; Bruining DH; Kammer PP; Becker BD; Tremaine WT
Inflamm Bowel Dis; 2013 May; 19(6):1107-11. PubMed ID: 23518805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
